Objective:A large number of studies suggest that abnormalities in nitric oxide (NO) synthesis may contribute to the development of preelampsia. We recently identified a variant within exon 7 of the endothelial NO synthase (eNOS) gene: G to T conversion at nucleotide position 894 resulting in replacement of glutamic acid with aspartic acid at codon 298 (Glu298Asp). We analyzed the association between the Glu298Asp eNOS gene variant and preeclampsia.
Study design:The study included 152 preeclampsia patients (35 mild, 80 severe, and 37 superimposed) and 170 control subjects. Screeing for the Glu298Asp eNOS gene variant was carried out by analysis of polymerase chain reaction-restriction fragment length polymorphism.
Results:The frequency of the Glu298Asp variant was significantly higher in the severe preclampsia group (28.8%) than in the control (14.1%; p < .01), superimposed preeclampsia (8.1%; p < .01), and mild preeclampsia (11.4%; p < .01) groups.
Conclusions:We conclude that the presence of the Glu298Asp eNOS gene could be a marker of increased risk of developing severe preeclampsia.
1. Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: Current concepts. Am J Obstet Gynecol1998;179:1359-1375.
2.
2. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: An endothelial cell disorder. Am J Obstet Gynecol1989;161:1200-1204.
3.
3. Sladek SM, Magness RR, Conrad KP. Nitric oxide and pregnancy. Am J Physiol1997;272:R441-R463.
4.
4. Magness RR, Rosenfeld CR, Hassan A, Shaul PW. Endothelial vasodilator production by uterine and systemic arteries. I. Effects of ANG II on PGI2 and NO in pregnancy. Am J Physiol1996;270:H1914-H1923.
5.
5. Magness RR, Shaw CE, Pherenetton TM, Zheng, J, Bird IM. Endothelial vasodilator production by uterine and systemic arteries. II. Pregnancy effects on NO synthase expression. Am J Physiol1997;272:H1730-H1740.
6.
6. Itoh H, Bird IM, Nakao K, Magness RR. Pregnancy increases soluble and particulate guanylate cylases and decreases the clearance receptor of natriuretic peptide in ovine uterine, but not systemic, arteries. Endocrinology1998;138:3329-3341.
7.
7. Buhimschi I, Yallampalli C, Chwalisz K, Garfield RE. Preclampsia-like conditions produced by nitric oxide inhibition: Effects of L-arginine, D-arginine and steroid homrones. Hum Reprod1995;10:2723-2730.
8.
8. Yoshimura M, Yasue H, Nakayama M, et al. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet1998;103:65-69.
9.
9. Shimasaki Y, Yasue H, Yoshimura M, et al. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol1998;31:1506-1510.
10.
10. Miyamoto Y, Saito Y, Kajiyama N, et al. Endothelial nitric oxide synthase gene is prositively associated with essential hypertension. Hypertension1998;32:3-8.
11.
11. National High Blood Pressure Education Program Working Group report on high school pressure in pregnancy. Am J Obstet Gynecol1990;163:1689-1172.
12.
12. Saiki RK, Scharf S, Faloona F, et al. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science1985;230:1350-1354.
13.
13. Ward K, Hata A. Jeunemaitre X, et al. A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet1993;4:59-61.
14.
14. Wilton AN, Kaya JA, Guo G, Brennecke SP, Cooper DW. Is angiotensinogen a good candidate gene for preeclampsia?Hypertens Pregnancy1995;14:251-260.
15.
15. Vuoricnen K, Remes A, Sormunen R, Tapanainen J, Hassinen IE. Placental mitochondrial DNA and respiratory chain enzymes in the etiology of preeclampsia. Obstet Gynecol1998;91:950-955.
16.
16. Kupferminc MJ, Eldor A, Steinman N, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med1999;340:9-13.
17.
17. Nagy B, Rigo J Jr, Fintor L, Karadi I, Toth T. Apolipoprotein E alleles in women with severe pre-eclampsia. J Clin Pathol1998;51:324-325.
18.
18. Chen G, Wilson R, Wang SH, Zheng HZ, Walker JJ, Mckillop JH. Tumor necrosis factor-alpha (TNF-α) gene polymorphism and expression in pre-eclampsia. Clin Exp Immunol1996;104:154-159.
19.
19. Powers RW, Minich LA, Lykins DL, Ness RB, Crombleholme WR, Robert JM. Methylenetetrahydrofolate reductase polymorphism, folate, and susceptibility to preeclampsia. J Soc Gynecol Investig1999;6:74-76.
20.
20. Jonsdottir LS, Arngrimsson R, Geirsson RT, Sigvaldason H, Sigfusson N. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand1995;74:772-776.
21.
21. Sibai BM, El-Nazer A, Conzalez-Ruizc A. Severe preeclampsiaeclampsia in young primigravid women: Subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol1986;155:1011-1016.
22.
22. Arngrimsson R, Hayward C, Nadaud S, et al. Evidence for a familial pregnancy-induced hypertension locus in the eNOS-gene region. Am J Hum Genet1997;61:354-362.
23.
23. Teasuro M, Thompson WC, Rogliani P, Qi L, Chaudhary PP, Moss J. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: Cleavage of proteins with aspartate vs. glutaate at position 298. Proc Natl Acad Sci U S A2000;97:2832-2835.
